Locations
Ontario, Canada · Toronto, ON, Canada · North York, Toronto, ON, Canada
Size
11-50 employees
founded in
2008
Plantform Corporation is a Canadian biotech company with a low-cost, proprietary manufacturing platform for a wide range of plant-made pharmaceuticals, including monoclonal antibodies, therapeutic proteins, and vaccines for the treatment of cancer, HIV/AIDS, Ebola virus, and other life-threatening illnesses. The company’s VIVOXPRESS® plant-based technology platform produces biopharmaceutical products in fully contained greenhouse environments. Plantform’s pipeline features both innovator and biosimilar products, including: • 3 biosimilar cancer drugs, leading with trastuzumab, a plant-produced version of the breast cancer drug Herceptin® • Innovator antibodies for HIV/AIDS, funded by the Government of Canada and the Bill & Melinda Gates Foundation • Innovator antibodies for treatment of Ebola virus (Sudan strain), with financial support from the National Research Council of Canada Industrial Research Assistance Program (NRC-IRAP) and in collaboration with the U.S. Army Medical Research
Something looks off?